A UAB pain specialist says the opioid epidemic will lead to profound changes in legitimate opioid use for pain management.
UAB is the only institution in Alabama chosen to date to participate in the TAPUR Study to help further understand targeted therapies in patients with advanced cancers.
Leading neuroscientist Ron Lazar joins UAB as director of the McKnight Brain Institute, a multidisciplinary research enterprise on learning and memory in aging.
Anezi Uzendu, M.D., has touched the hearts of many patients and colleagues in his time at UAB; but now that reach is bigger than ever, after his own heart failed him.
This active drug-delivery system addresses the limitations seen for the anti-cancer drug BA-TPQ — poor solubility and low bioavailability.
With both Rocky Mountain Spotted Fever and Lyme disease increasing in recent years, UAB wilderness medicine physician says it’s important to dress properly and to perform tick checks after woodland excursions.
UAB's Air Force Special Operations Surgical Team was honored following a recent overseas deployment when the team commander received a prestigious award.
Stephen Aller, Ph.D., has been recently recognized for integrating leading-edge technology, “cryo-EM” into his research on membrane protein structure, by the National Institutes of Health.
Page 149 of 306